Changsheng Wu

Prof. Changsheng Wu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
PZPeng Zhang
Peng Zhang
ZZZheng Zhang
Zheng Zhang
LZLijuan Zhang
Lijuan Zhang
JWJingjing Wang
Jingjing Wang
CWChangsheng Wu
Changsheng Wu
• The phylogenetic distribution of GT1 family enzymes showed domain-dependent pattern. • The domain-dependent characterized GTs showed distinct substrates spectrum. • Two regions that discriminate the GT1 enzymes from different domains were identified.

8 February 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CWChangsheng Wu
Changsheng Wu
ZSZhuo Shang
Zhuo Shang
CLChristophe Lemetre
Christophe Lemetre
MTMelinda A. Ternei
Melinda A. Ternei
SBSean F. Brady
Sean F. Brady

18 January 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
CWChangsheng Wu
Changsheng Wu
HHHelga U. van der Heul
Helga U. van der Heul
AMAlexey V. Melnik
Alexey V. Melnik
JLJens Luebben
Jens Luebben
PDPieter C. Dorrestein
Pieter C. Dorrestein
GWGilles Van Wezel
Gilles Van Wezel
The angucyclines form the largest family of polycyclic aromatic polyketides, and have been studied extensively. Herein, we report the discovery of lugdunomycin, an angucycline‐derived polyketide, produced by Streptomyces species QL37. Lugdunomycin has unique structural characteristics, including a heptacyclic ring system, a spiroatom, two all‐carbon stereocenters, and a benzaza‐[4,3,3]propellane motif. Considering the structural novelty, we propose that lugdunomycin represents a novel subclass of aromatic polyketides. Metabolomics, combined with MS‐based molecular networking analysis of Streptomyces sp. QL37, elucidated 24 other rearranged and non‐rearranged angucyclines, 11 of which were previously undescribed. A biosynthetic route for the lugdunomycin and limamycins is also proposed. This work demonstrates that revisiting well‐known compound families and their producer strains still is a promising approach for drug discovery.

25 January 2022 in ACS Synthetic Biology
Verified
Journal Article
Closed access
LZLi-Juan Zhang
Li-Juan Zhang
DWDe-Gao Wang
De-Gao Wang
PZPeng Zhang
Peng Zhang
CWChangsheng Wu
Changsheng Wu
YLYue-zhong Li
Yue-zhong Li

23 February 2024 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
CWChao-Yi Wang
Chao-Yi Wang
JHJia-Qi Hu
Jia-Qi Hu
DWDe-Gao Wang
De-Gao Wang
YLYue-zhong Li
Yue-zhong Li
CWChangsheng Wu
Changsheng Wu
This review presents a comprehensive overview of recent advances in the discovery methodologies, new structures, bioactivities, and unique biosynthetic logics of myxobacterial natural products reported from January 2017 to November 2023.

27 July 2021 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
YLYuelan Li
Yuelan Li
LZLi Zhuo
Li Zhuo
Xiaobin LiXiaobin Li
Xiaobin Li
YZYongqiang Zhu
Yongqiang Zhu
SWShuge Wu
Shuge Wu
CWChangsheng Wu
Changsheng Wu